Zynerba Pharmaceuticals, Inc.Equity-NMS: ZYNE
Equity-NMS: ZYNE
$1.3
NA
(9:00 pm IST)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$1.30
Open
$1.30
1Y
181.39%
5Y
-24.17%
Shares O/S
53.94M
Market cap
70.12M
Insights
ZYNE price is below its 200 day moving average
ZYNE is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.

2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD). .


FAQs

Can I buy Zynerba Pharmaceuticals, Inc. shares in India?
How to buy Zynerba Pharmaceuticals, Inc. shares in India?
What is the share price of Zynerba Pharmaceuticals, Inc.?
What is the Market Capitalization of Zynerba Pharmaceuticals, Inc.?
What is the PE ratio of Zynerba Pharmaceuticals, Inc.?
Is Zynerba Pharmaceuticals, Inc. a good stock to buy?
In which sector / industry does Zynerba Pharmaceuticals, Inc. operate?